Post-approval studies (Phase 4)Study completedNCT00871104What this trial is testingFosfomycin Plus Imipenem for Treatment of Infective EndocarditisWho this might be right forInfective Endocarditis Juan A. Arnaiz 50
Testing effectiveness (Phase 2)Looking for participantsNCT04886284What this trial is testingCombination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus BacteremiaWho this might be right forStaphylococcus Aureus BacteremiaStaphylococcus Aureus SepticemiaStaphylococcal Sepsis+1 more Todd C. Lee MD MPH FIDSA 60
Large-scale testing (Phase 3)Study completedNCT00770341What this trial is testingMK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)Who this might be right forStaphylococcal Infection Merck Sharp & Dohme LLC 122
Not applicableNo Longer AvailableNCT04597242What this trial is testingExpanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA BacteremiaWho this might be right forMRSA Bloodstream InfectionMRSA BacteremiaMRSA Right-sided Endocarditis+1 more ContraFect
Large-scale testing (Phase 3)Study completedNCT00093067What this trial is testingDaptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. AureusWho this might be right forBacterial EndocarditisBacteremia Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Large-scale testing (Phase 3)Not Yet RecruitingNCT07345325What this trial is testingRifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve EndocarditisWho this might be right forInfective Endocarditis Nantes University Hospital 422
Post-approval studies (Phase 4)Looking for participantsNCT06650501What this trial is testingDabigatran vs. Apixaban, Edoxaban, or Rivaroxaban as Anti-thrombotic Therapy in Patients With S. Aureus BacteremiaWho this might be right forStaphylococcus Aureus EndocarditisStaphylococcus Aureus SepticemiaStaphylococcus Aureus Bacteremia+3 more Emily McDonald 300
Large-scale testing (Phase 3)Ended earlyNCT04160468What this trial is testingDirect Lysis of Staph Aureus Resistant Pathogen Trial of ExebacaseWho this might be right forStaphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis ContraFect 259
Large-scale testing (Phase 3)Looking for participantsNCT07253688What this trial is testingAdjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. AureusWho this might be right forStaphylococcus Aureus EndocarditisProsthetic Valve Endocarditis Todd C. Lee MD MPH FIDSA 330
Testing effectiveness (Phase 2)WithdrawnNCT05329168What this trial is testingERAdicate S. Aureus in Patients With Bacteremia and EndocarditisWho this might be right forBacteremia Due to Staphylococcus AureusLeft Sided Infective Endocarditis (Disorder)Right Sided Infective Endocarditis (Disorder)+1 more Lysovant
Not applicableStudy completedNCT01731483What this trial is testingCoagulation and Fibrinolysis as Virulence Factors for Invasive Staphylococcus Aureus and Streptococcus InfectionsWho this might be right forInfective EndocarditisNecrotizing Fasciitis Universitaire Ziekenhuizen KU Leuven 89
Post-approval studies (Phase 4)Looking for participantsNCT06637332What this trial is testingDaptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus BacteremiaWho this might be right forStaphylococcus Aureus SepticemiaStaphylococcus Aureus BacteremiaS. Aureus Bacteremia+2 more Todd C. Lee MD MPH FIDSA 300
Not applicableUnknownNCT05522764What this trial is testingPredictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly Staphylococcus Aureus Bacteriuria, and Time to Blood Culture PositivityWho this might be right forBacteremiaEndocarditis, Bacterial Fondation Hôpital Saint-Joseph 247
Post-approval studies (Phase 4)UnknownNCT02443064What this trial is testingPharmacokinetics/ Pharmacodynamics (PK/PD) Study of VancomycinWho this might be right forBlood Stream InfectionsEndocarditisMRSA Zhejiang University 100
Post-approval studies (Phase 4)Ended earlyNCT00638157What this trial is testingPhase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)Who this might be right forInfective Endocarditis Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Not applicableLooking for participantsNCT06495697What this trial is testingPlasma Pharmacological Monitoring of M Penicillins in Methicillin-sensitive Staphylococcus Aureus BacteremiaWho this might be right forStaphylococcus Aureus Infection University Hospital, Strasbourg, France 200
Large-scale testing (Phase 3)Study completedNCT03138733What this trial is testingCeftobiprole in the Treatment of Patients With Staphylococcus Aureus BacteremiaWho this might be right forStaphylococcus Aureus Bacteremia Basilea Pharmaceutica 390
Not applicableUnknownNCT04257292What this trial is testingNExt-Generation Sequencing and Cell Culture-based Characterization of S. Aureus in Infective EndocarditisWho this might be right forInfective EndocarditisInfection Staphylococcal Jena University Hospital 10
Large-scale testing (Phase 3)Ended earlyNCT02208063What this trial is testingTelavancin Staphylococcus Aureus (S. Aureus) Bacteremia TrialWho this might be right forBacteremia Cumberland Pharmaceuticals 121
Not applicableUnknownNCT05862025What this trial is testingEvaluation of the Usefulness of Echocardiography in Patients With Staphylococcus Aureus Bacteremia (ET-AUREUS Study).Who this might be right forStaphylococcus Aureus BacteremiaInfective Endocarditis Puerta de Hierro University Hospital 470